Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Research at Pfizer leads to potent CysLT1 antagonist

April 2, 1998

Mochida prepares novel agents for disorders associated with eosinophilia

April 2, 1998

Moguisteine, a potential agent for treating allergic cough

March 31, 1998

Peptimmune and Peptide Therapeutics form asthma, autoimmune disease collaboration

March 30, 1998

Inspire, NeoGenesis form respiratory drugs collaboration

March 27, 1998

Byk Gulden claims PDE IV inhibitors for respiratory disorders, dermatoses

March 27, 1998

Novel compounds for allergic/inflammatory disorders discovered at Astra

March 27, 1998

TOBI now available for CF patients with P. aeruginosa

March 26, 1998

HSR-609: a potent and insurmountable H1 antagonist in vitro

March 26, 1998

Hoechst discovers inhibitors of various inflammatory mediators

March 25, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...